Dr. Kooienga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Rampart Way
Suite 300b
Denver, CO 80230Phone+1 303-364-4775
Education & Training
University of ColoradoFellowship, Nephrology, 2004 - 2007- University of ColoradoResidency, Internal Medicine, 2000 - 2004
Wayne State University School of MedicineClass of 2000
Certifications & Licensure
CO State Medical License 2003 - 2025
KS State Medical License 2012 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- Safety and Efficacy of Vadadustat Once Daily and Three Times Weekly in Patients With Dialysis-Dependent CKD With Anemia.Laura Kooienga, Steven Burke, Amarnath Kathresal, Wenli Luo, Zhihui Yang
Kidney360. 2024-11-01 - Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study.Stephen R Ash, Daniel Batlle, Jessica Kendrick, Yemisi Oluwatosin, Laura Kooienga
Kidney360. 2024-06-01 - 44 citationsEfficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler
Lancet. 2023-12-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
